Battleground? Issuer objections to OKXICE tokenised stocks reach 50.

By yesterday evening, 50 companies had objected to OKXICE tokenised stocks, the planned 24/7 trading of US shares on the venture between OKX and Intercontinental Exchange. Forty-three of them are on its original target list and an executive at a Nasdaq-listed company alleges that Nasdaq encouraged objections, while Nasdaq denies involvement in a related newspaper advertisement.

OKXICE tokenised stocks and the SEC innovation exemption

The SEC innovation exemption lets issuers object to a third-party venue trading their tokenised shares. A valid objection stops that venue from trading the company's tokenised shares under the exemption.

OKXICE proposed tokenising shares of more than sixty US-listed companies. Each token would be backed one for one by real stock held through registered broker-dealers, with holders receiving rights such as dividends and voting. Trading would run 24/7 through permissioned Uniswap v4 pools on OKX's X Layer blockchain, settled in stablecoins.

The count of issuer objections has climbed quickly. A notice published on 26 October listed 26 objectors. The next notice, dated 27 October, listed 33 after Coca-Cola, JPMorgan Chase, Dell, AMD, Adobe, Applied Materials and Sandisk were added. By 29 October the venue faced objections on 39 of its 63 intended tokens. By 3 November the total stood at 50: 43 on the original list plus seven companies outside it.

The objectors named include JPMorgan, Walmart, Nvidia, Coca-Cola and Goldman Sachs. Their stated concerns cover share prices, liquidity and volatility, along with shareholder rights, custody and transparency.

The maths is simple. Going from 26 objectors on 26 October to 50 on 3 November is a significant rise in just eight days, which almost doubles the count. More than two thirds of the original target list has now objected.

Nasdaq allegations and the Wall Street Journal advertisement

A full-page Wall Street Journal advertisement urged company executives to oppose tokenisation of their shares. Its QR code linked to Nasdaq's FAQ on its objections to the SEC framework for tokenised securities venues. A conservative-leaning non-profit paid for it, and the final source of funding remains unclear.

Nasdaq denies involvement. It says it has never contributed to the non-profit and did not authorise use of its FAQ or the link.

A separate allegation comes from an executive at a Nasdaq-listed company, who says a Nasdaq representative suggested objecting to OKXICE and offered a call to explain the reasons. The executive is not named. A Nasdaq spokesperson declined to comment on the claim about its representatives.

Andrew Cuomo, who leads OKXICE, answered the advertisement on a press call with "game on" and described the dispute as competition between trading venues. Mike Cagney, chief executive of Figure, questioned the venue's trading model in a post on 2 November, raising execution quality, margin availability and access to a stock lending market.

Nasdaq has its own route to tokenised equity. It invested $100 million in Kraken's parent Payward in September, plans a Nasdaq Equity Token designed to operate within existing securities rules, and says it will exclude its own shares from the SEC framework. A rival venue, TSV LLC, expects tokenised trading in Canton Strategic Holdings shares to begin as early as 2 November, and the issuer's endorsement removes the separate 30-day objection requirement.

The earlier coverage of the OKXICE filing and of the SEC officials' expectation on issuer objection set out how the exemption was meant to work. The SIFMA letter on the exemption shows the objection right was already contested before the first venue launched.

UK founders and the question of issuer consent

This count appears to measures one thing: how many issuers will accept third-party tokenisation of their shares. The current exemption puts the lever with the issuer, and 50 issuers have pulled it. The objections though, do not necessarily oppose tokenisation itself but highlight the difficulty for platforms that tokenise shares without issuer involvement.

A UK private company has no equivalent public rule, partly because its shares do not normally trade on a venue. Control normally sits in the articles of association and any shareholders' agreement, which usually gives the board a say over share transfers. So a founder weighing a tokenised cap table or a secondary market faces the same question the listed companies answered: who may create tradable claims on the shares, and with whose consent.

The obvious and practical first step is to read the transfer provisions before a platform conversation, not after one. This is general information, not legal advice.

The venue's backers have a counter argument and describe the dispute as competition between trading venues. Nineteen of the original target companies have not objected, and whether those silent issuers want trading, or simply have not acted, is currently unknown.

Key takeaways

• Fifty companies had objected to OKXICE tokenised stocks by 3 November 2026, up from 26 on 26 October.

• Forty-three of the objectors are on the venture's original target list, which is more than two thirds of it.

• Nasdaq denies involvement in the Wall Street Journal advertisement and declined to comment on an executive's claim that its representative encouraged objections.

• Under the SEC innovation exemption the objection right sits with the issuer, so consent is the design question for any tokenised equity venue.

• UK private company founders should read their articles and shareholders' agreement on share transfers before agreeing to any tokenisation or secondary platform.